An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy
Excerpt
The guideline article “Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations” in this journal for the management of hypersensitivity reactions (HSR) to this group of chemotherapy agents is useful in clinical practice [...]
Share and Cite
Bahl, M.; Dean, T. An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Curr. Oncol. 2015, 22, 220-221. https://doi.org/10.3747/co.22.2400
Bahl M, Dean T. An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Current Oncology. 2015; 22(3):220-221. https://doi.org/10.3747/co.22.2400
Chicago/Turabian StyleBahl, Mala, and Terry Dean. 2015. "An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy" Current Oncology 22, no. 3: 220-221. https://doi.org/10.3747/co.22.2400
APA StyleBahl, M., & Dean, T. (2015). An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy. Current Oncology, 22(3), 220-221. https://doi.org/10.3747/co.22.2400